Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Property, Plant & Equipment (Net) history
Currency unavailable · from the balance sheet
No Property, Plant & Equipment (Net) data reported for this period type.
Property, Plant & Equipment (Net) vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | Jun 2026 | $34.12M USD | -11.5% | +98.8% | 6.1% |
| Mar 2026 | $13.32M USD | -15.0% | -11.4% | 4.0% | |
| Jun 2026 | $3.46M USD | -72.8% | +36.2% | 0.4% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $3.1M USD | +39.3% | +79.2% | 0.3% |
| Mar 2026 | $2.89M USD | +206.5% | — | 1.5% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €1.68M EUR | — | — | 1.0% |
| Mar 2026 | $983K USD | -36.2% | -13.8% | 0.5% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -13.2% | +36.2% | 0.8% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.